Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Détails
ID Serval
serval:BIB_09C9F1574AD1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Périodique
Annals of Oncology
Collaborateur⸱rice⸱s
ESMO / European Sarcoma Network Working Group
Contributeur⸱rice⸱s
Blay JY., Blomqvist C., Bonvalot S., Boukovinas I., Casali PG., De Alava E., Dei Tos AP. , Dirksen U., Duffaud F., Eriksson M., Fedenko A., Ferrari A., Ferrari S., del Muro XG. , Gelderblom H., Grimer R., Gronchi A., Hall KS., Hassan B., Hogendoorn P., Hohenberger P., Issels R., Joensuu H., Jost L., Jurgens H., Kager L., Le Cesne A., Leyvraz S., Martin J., Merimsky O., Nishida T., Picci P., Reichardt P., Rutkowski P., Schlemmer M., Sleijfer S., Stacchiotti S., Taminiau A., Wardelmann E.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
2012
Volume
23 Suppl 7
Numéro
Suppl 7
Pages
vii49-vii55
Langue
anglais
Notes
Publication types: Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Antineoplastic Agents/therapeutic use, Combined Modality Therapy, DNA Mutational Analysis, Disease Management, Gastrointestinal Neoplasms/diagnosis, Gastrointestinal Neoplasms/genetics, Gastrointestinal Stromal Tumors/diagnosis, Gastrointestinal Stromal Tumors/genetics, Humans, Neoplasm Staging, Piperazines/therapeutic use, Prognosis, Pyrimidines/therapeutic use, Risk Assessment, Treatment Outcome
Pubmed
Web of science
Open Access
Oui
Création de la notice
26/12/2012 17:43
Dernière modification de la notice
20/08/2019 13:31
Données d'usage
